The antibody S309, first identified in a blood sample from a recovered SARS patient, inhibits the coronavirus that causes COVID-19, researchers report.
Using microchip technology boosts the accuracy of antibody testing of patients recovered from COVID-19. That would help find convalescent plasma donors.
Anne Warde-UC Irvine •
futurity
April 28, 2020
•
~4 min
Plasma therapy would use antibodies from the blood serum of COVID-19 survivors to boost the immunity of newly infected patients and those at risk of contracting it.
Johns Hopkins University •
futurity
March 17, 2020
•
~4 min
Plasma therapy would use antibodies from the blood serum of COVID-19 survivors to boost the immunity of newly infected patients and those at risk of contracting it.
Johns Hopkins University •
futurity
March 17, 2020
•
~4 min